Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Multinodular goiter.
The thyroid and its disease.
pp. 611-633
[2.]
A.R. Hermus, D.A. Huysmans.
Clinical manifestations and treatment of nontoxic diffuse and nodular goiter. The thyroid: a fundamental and clinical text.
pp. 866-871
[3.]
S.J. Bonnema, F.N. Bennedback, W.M. Wiersinga, L. Hegedüs.
Management of the nontoxic multinodular goitre: a European questionnaire study.
Clin Endocrinol (Oxf), 53 (2000), pp. 5-12
[4.]
A. Berghout, W.M. Wiersinga, H.A. Drexhage, N.J. Smits, J.L. Touber.
Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic nontoxic goiter.
Lancet, 336 (1990), pp. 193-197
[5.]
D.A. Huysmans, F.H. Corstens, P.W.C. Kloppenborg.
Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine.
J Nucl Med, 32 (1991), pp. 27-30
[6.]
N. Gómez-Arnaiz, J. Maravall, J.M. Gómez, A. Gumà, E. Andia, J. Mora.
Eficacia del tratamiento con radioyodo del adenoma tiroideo y bocio multinodular tóxicos.
Rev Clin Esp, 199 (1999), pp. 637-640
[7.]
W. Keiderling, D. Emrich, C. Hauswaldi, G. Hoffmann.
Ergebnisse der radiojodverkleinerungstherapie euthyreoter strumen.
Dtsch Med Wochenschr, 89 (1964), pp. 453-457
[8.]
B. Klein, E. Klein, F.A. Horster.
Results of fractionated radioiodine therapy in 696 patients with hyperthyroidism and 690 patients with non-toxic goiter.
Nuklearmedizin, 28 (1989), pp. 129-136
[9.]
T.W.H. Kay, M.C. d'Emben, J.T. Andrews, F.I.R. Martin.
Treatment of non-toxic multinodular goiter with radioactive iodine.
Am J Med, 84 (1988), pp. 19-22
[10.]
J. Verelst, M. Bonnyns, D. Glinoer.
Radioiodine therapy in voluminous multinodular non-toxic goitre.
Acta Endocrinol (Copenh), 122 (1990), pp. 417-421
[11.]
L. Hegedüs, B.M. Hansen, N. Knudsen, J.M. Hansen.
Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.
BMJ, 297 (1988), pp. 661-662
[12.]
B. Nygaard, L. Hegedüs, M. Gervil, H. Hjalgrim, P.S. Jensen, J.M. Hansen.
Radioiodine treatment of multinodular non-toxic goitre.
BMJ, 307 (1993), pp. 828-832
[13.]
M.F. Wesche, M.M. Tiel-van Bull, N.J. Smits, W.M. Wiersinga.
Reduction in goiter size by I-131 therapy in patients with nontoxic multinodular goiter.
Eur J Endocrinol, 132 (1995), pp. 86-87
[14.]
J.M. De Klerk, J.W. Van Isselt, A. Van Dijk.
Iodine-131 therapy in sporadic nontoxic goiter.
J Nucl Med, 38 (1997), pp. 372-376
[15.]
D.A.K.C. Huysmans, R.M.M. Hermus, F.H.M. Corstens, J.O. Barentsz, P.W.C. Kloppenborg.
Large, compressive goiters treated with radioiodine.
Ann Intern Med, 121 (1994), pp. 757-762
[16.]
D.A. Huysmans, W-A Nieuwlaat, R.J. Erdtsieck, A.P. Schellekens, J.W. Bus, B. Bravenboer, et al.
Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodine uptake in nontoxic nodular goiter.
J Clin Endocrinol Metab, 85 (2000), pp. 3592-3596
[17.]
A.H. Maurer, N.D. Charkes.
Radioiodine treatment for nontoxic multinodular goiter.
J Nucl Med, 40 (1999), pp. 1313-1316
[18.]
B. Nygaard, J. Faber, L. Hegedüs.
Acute changes in thyroid volume and function following 131I therapy of multinodular goitre.
Clin Endocrinol (Oxf), 41 (1994), pp. 715-718
[19.]
D.A.K.C. Huysmans, A.R.M.M. Hermus, M. Edelbroek, J.O. Barentsz, P.W.C. Kloppenborg, F.H.M. Corstens.
Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Thyroid, 7 (1997), pp. 535-539
[20.]
B. Nygaard, J. Faber, A. Vejet, J.E.M. Hansen.
Thyroid volume and function after 131I treatment of diffuse non-toxic goitre.
Clin Endocrinol (Oxf), 46 (1997), pp. 493-496
Copyright © 2002. Sociedad Española de Endocrinología y Nutrición